Beta Bionics Inc.

NASDAQ: BBNX · Real-Time Price · USD
17.04
0.33 (1.97%)
At close: Aug 15, 2025, 3:59 PM
17.04
0.03%
After-hours: Aug 15, 2025, 05:33 PM EDT

Beta Bionics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
30.43M 26.57M 27.68M
Short-Term Investments
73.14M 70.18M n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
5.3M 221K 193K
Receivables
12M 4.45M n/a
Inventory
13.32M 1.25M n/a
Other Current Assets
1.05M 275K 250K
Total Current Assets
132.92M 103.62M 28.47M
Property-Plant & Equipment
11.42M 6.2M 6.87M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
16.72M 6.42M 7.06M
Total Assets
149.65M 110.04M 35.53M
Account Payables
2.85M 1.17M 430K
Deferred Revenue
939K n/a n/a
Short-Term Debt
1.53M n/a n/a
Other Current Liabilities
9.41M 1.14M 1.32M
Total Current Liabilities
21.15M 10.61M 8.87M
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
44.9M 37.83M 10.5M
Total Long-Term Liabilities
52.48M 40.83M 13.65M
Total Liabilities
73.63M 51.43M 22.53M
Total Debt
7.25M 4.22M 4.13M
Common Stock
1K 1K 1K
Retained Earnings
-296.74M -229.66M -185.56M
Comprehensive Income
65K 137K n/a
Shareholders Equity
76.01M 58.61M 13M
Total Investments
73.14M 70.18M n/a